Nature Medicine publishes results of H-drug combined with chemotherapy for first-line treatment of esophageal squamous cell carcinoma

Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers

Sagara Hospital, Japan

UCLA Health University of California, Los Angeles Medical Center.

Immune And Astrazeneca Launch Strategic Research Collaboration To Accelerate Drug Target Discovery

New Discovery: Drug For Parkinson's Disease That May Reduce Chemotherapy Side Effects And Boost Cancer-Fighting Power!